In response to compressed drug development timelines, oftentimes settling for sub-optimal dose form design and manufacturability considerations complicate downstream development steps. Join this webinar to learn how an integrated dose form design strategy based on analyzing data from a molecule’s physicochemical properties, ADME/PK, manufacturability and stability, plus patient and market considerations can help in creating better treatments.

Key Learning Objectives:

• Key considerations for pharmaceutical companies and biotech start-ups when engaging a consultant or scientific advisory on a long-term strategy.
• Advantages of data-driven collaborative approaches to determine optimal dose forms.
• Introduction to Catalent’s OptiDose Design Solution and insights into key patient considerations impacting dose form selection.
• Learn how Catalent’s Scientific Advisors operationalize the assessment process within the overall drug development program, with example scenarios.